GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the broadly neutralizing anti-HIV Fab F105

Analyse Crystal structure of the broadly neutralizing anti-HIV Fab F105 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1U6A
Type
protein
Length
436 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
F105 light chain; F105 heavy chain
UniProt
Q6N089
Pockets
3 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LF105 light chainprotein2147% helix, 57% strand—
HF105 heavy chainprotein2229% helix, 50% strandQ6N089

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16090.630.7469empty
2520.280.7416empty
3550.250.7214empty

Interfaces

1 interface between chains.

  • L–H · 1923 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1U6A · Crystal Structure of the Broadly Neutralizing Anti-HIV Fab F105 · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.